Alavi N, Hirji A, Sutton C, Naeem F Online CBT Is Effective in Overcoming Cultural and Language Barriers in Patients With Depression. J Psychiatr Pract. 2016 Jan;22(1):2-8. doi: 10.1097/PRA.0000000000000119.
Alavi N, Hirji A The Efficacy of PowerPoint-based CBT Delivered Through Email: Breaking the Barriers to Treatment for Generalized Anxiety Disorder. J Psychiatr Pract. 2020 Mar;26(2):89-100. doi: 10.1097/PRA.0000000000000455.
Andersson G, Titov N Advantages and limitations of Internet-based interventions for common mental disorders. World Psychiatry. 2014 Feb;13(1):4-11. doi: 10.1002/wps.20083.
Andrews G, Davies M, Titov N Effectiveness randomized controlled trial of face to face versus Internet cognitive behaviour therapy for social phobia. Aust N Z J Psychiatry. 2011 Apr;45(4):337-40. doi: 10.3109/00048674.2010.538840. Epub 2011 Feb 16.
Bados A, Balaguer G, Saldana C The efficacy of cognitive-behavioral therapy and the problem of drop-out. J Clin Psychol. 2007 Jun;63(6):585-92. doi: 10.1002/jclp.20368.
Baltieri DA, Daro FR, Ribeiro PL, de Andrade AG Comparing topiramate with naltrexone in the treatment of alcohol dependence. Addiction. 2008 Dec;103(12):2035-44. doi: 10.1111/j.1360-0443.2008.02355.x. Epub 2008 Oct 8.
Barrick C, Connors GJ Relapse prevention and maintaining abstinence in older adults with alcohol-use disorders. Drugs Aging. 2002;19(8):583-94. doi: 10.2165/00002512-200219080-00004.
Carroll KM, Kiluk BD Cognitive behavioral interventions for alcohol and drug use disorders: Through the stage model and back again. Psychol Addict Behav. 2017 Dec;31(8):847-861. doi: 10.1037/adb0000311. Epub 2017 Aug 31.
Carroll, K M. (1996). Relapse prevention as a psychosocial treatment: A review of controlled clinical trials. Experimental and Clinical Psychopharmacology, 4(1), 46-54. https://doi.org/10.1037/1064-1297.4.1.46
Castillo-Carniglia A, Keyes KM, Hasin DS, Cerda M Psychiatric comorbidities in alcohol use disorder. Lancet Psychiatry. 2019 Dec;6(12):1068-1080. doi: 10.1016/S2215-0366(19)30222-6. Epub 2019 Oct 17.
Chick JD Book Review: Alcoholism Treatment in Transition. 1981
Clay JM, Parker MO Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis? Lancet Public Health. 2020 May;5(5):e259. doi: 10.1016/S2468-2667(20)30088-8. Epub 2020 Apr 8. No abstract available.
Connor JP, Haber PS, Hall WD Alcohol use disorders. Lancet. 2016 Mar 5;387(10022):988-998. doi: 10.1016/S0140-6736(15)00122-1. Epub 2015 Sep 3. Erratum In: Lancet. 2016 Mar 5;387(10022):944. Lancet. 2016 Mar 5;387(10022):944.
Cougle JR, Summers BJ, Allan NP, Dillon KH, Smith HL, Okey SA, Harvey AM Hostile interpretation training for individuals with alcohol use disorder and elevated trait anger: A controlled trial of a web-based intervention. Behav Res Ther. 2017 Dec;99:57-66. doi: 10.1016/j.brat.2017.09.004. Epub 2017 Sep 19.
Da BL, Im GY, Schiano TD Coronavirus Disease 2019 Hangover: A Rising Tide of Alcohol Use Disorder and Alcohol-Associated Liver Disease. Hepatology. 2020 Sep;72(3):1102-1108. doi: 10.1002/hep.31307.
Dawson DA, Grant BF, Li TK Quantifying the risks associated with exceeding recommended drinking limits. Alcohol Clin Exp Res. 2005 May;29(5):902-8. doi: 10.1097/01.alc.0000164544.45746.a7.
Drinking levels defined National Institute on Alcohol Abuse and Alcoholism. https://www.niaaa.nih.gov/alcohol-health/overview-alcohol-consumption/moderate-binge-drinking.
Fernandez E, Woldgabreal Y, Day A, Pham T, Gleich B, Aboujaoude E Live psychotherapy by video versus in-person: A meta-analysis of efficacy and its relationship to types and targets of treatment. Clin Psychol Psychother. 2021 Nov;28(6):1535-1549. doi: 10.1002/cpp.2594. Epub 2021 May 5.
Gatchel RJ, Mayer TG, Choi Y, Chou R Validation of a consensus-based minimal clinically important difference (MCID) threshold using an objective functional external anchor. Spine J. 2013 Aug;13(8):889-93. doi: 10.1016/j.spinee.2013.02.015. Epub 2013 Mar 21.
Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, Pickering RP, Kaplan K Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004 Aug;61(8):807-16. doi: 10.1001/archpsyc.61.8.807.
Heather N, Stockwell T The Essential Handbook of Treatment and Prevention of Alcohol Problems. J. Wiley; 2004
Hunt WA, Barnett LW, Branch LG Relapse rates in addiction programs. J Clin Psychol. 1971 Oct;27(4):455-6. doi: 10.1002/1097-4679(197110)27:43.0.co;2-r. No abstract available.
Irvin JE, Bowers CA, Dunn ME, Wang MC Efficacy of relapse prevention: a meta-analytic review. J Consult Clin Psychol. 1999 Aug;67(4):563-70. doi: 10.1037//0022-006x.67.4.563.
Jordans MJD, Luitel NP, Garman E, Kohrt BA, Rathod SD, Shrestha P, Komproe IH, Lund C, Patel V Effectiveness of psychological treatments for depression and alcohol use disorder delivered by community-based counsellors: two pragmatic randomised controlled trials within primary healthcare in Nepal. Br J Psychiatry. 2019 Aug;215(2):485-493. doi: 10.1192/bjp.2018.300. Epub 2019 Jan 25.
Kranzler HR, Soyka M Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review. JAMA. 2018 Aug 28;320(8):815-824. doi: 10.1001/jama.2018.11406.
Litman GK, Stapleton J, Oppenheim AN, Peleg M An instrument for measuring coping behaviours in hospitalized alcoholics: implications for relapse prevention treatment. Br J Addict. 1983 Sep;78(3):269-76. doi: 10.1111/j.1360-0443.1983.tb02511.x. No abstract available.
Low-risk alcohol drinking guidelines Canada.ca. https://www.canada.ca/en/health-canada/services/substance-use/alcohol/low-risk-alcohol-drinking-guidelines.html. Published July 5, 2021
Magill M, Ray L, Kiluk B, Hoadley A, Bernstein M, Tonigan JS, Carroll K A meta-analysis of cognitive-behavioral therapy for alcohol or other drug use disorders: Treatment efficacy by contrast condition. J Consult Clin Psychol. 2019 Dec;87(12):1093-1105. doi: 10.1037/ccp0000447. Epub 2019 Oct 10.
McCrady BS Alcohol use disorders and the Division 12 Task Force of the American Psychological Association. Psychol Addict Behav. 2000 Sep;14(3):267-76.
Miller PJ, Ross SM, Emmerson RY, Todt EH Self-efficacy in alcoholics: clinical validation of the Situational Confidence Questionnaire. Addict Behav. 1989;14(2):217-24. doi: 10.1016/0306-4603(89)90052-x.
Miller WR, Wilbourne PL Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders. Addiction. 2002 Mar;97(3):265-77. doi: 10.1046/j.1360-0443.2002.00019.x.
Monti, P M., Kadden, R. M., Rohsenow, D. J., Cooney, N. L., & Abrams, D. B. (2002). (2nd ed.). Guilford Press.
Probst C, Manthey J, Martinez A, Rehm J Alcohol use disorder severity and reported reasons not to seek treatment: a cross-sectional study in European primary care practices. Subst Abuse Treat Prev Policy. 2015 Aug 12;10:32. doi: 10.1186/s13011-015-0028-z.
Rehm J The risks associated with alcohol use and alcoholism. Alcohol Res Health. 2011;34(2):135-43.
Rollnick S, Heather N, Gold R, Hall W Development of a short 'readiness to change' questionnaire for use in brief, opportunistic interventions among excessive drinkers. Br J Addict. 1992 May;87(5):743-54. doi: 10.1111/j.1360-0443.1992.tb02720.x.
Rosner B Fundamentals of Biostatistics. 7th ed. Boston, MA: Brooks/Cole; 2011
Sharma A, Das K, Sharma S, Ghosh A Feasibility and preliminary effectiveness of internet-mediated 'relapse prevention therapy' for patients with alcohol use disorder: A pilot study. Drug Alcohol Rev. 2022 Mar;41(3):641-645. doi: 10.1111/dar.13395. Epub 2021 Oct 27.
Sinha R The role of stress in addiction relapse. Curr Psychiatry Rep. 2007 Oct;9(5):388-95. doi: 10.1007/s11920-007-0050-6.
Sobell MB, Sobell LC Controlled drinking after 25 years: how important was the great debate? Addiction. 1995 Sep;90(9):1149-53; discussion 1157-77. No abstract available.
Stevanovic D Quality of Life Enjoyment and Satisfaction Questionnaire-short form for quality of life assessments in clinical practice: a psychometric study. J Psychiatr Ment Health Nurs. 2011 Oct;18(8):744-50. doi: 10.1111/j.1365-2850.2011.01735.x. Epub 2011 May 5.
The Lancet Gastroenterology Hepatology Drinking alone: COVID-19, lockdown, and alcohol-related harm. Lancet Gastroenterol Hepatol. 2020 Jul;5(7):625. doi: 10.1016/S2468-1253(20)30159-X. No abstract available.
Tull MT, Edmonds KA, Scamaldo KM, Richmond JR, Rose JP, Gratz KL Psychological Outcomes Associated with Stay-at-Home Orders and the Perceived Impact of COVID-19 on Daily Life. Psychiatry Res. 2020 Jul;289:113098. doi: 10.1016/j.psychres.2020.113098. Epub 2020 May 12.
Zelviene P, Jovarauskaite L, Truskauskaite-Kuneviciene I The Psychometric Properties of the Resilience Scale (RS-14) in Lithuanian Adolescents. Front Psychol. 2021 May 21;12:667285. doi: 10.3389/fpsyg.2021.667285. eCollection 2021.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.